While previous studies have reported an association between serum FGF23 and radiographic markers of cerebral small vessel disease and cognitive performance,[4, 5] there have been no studies to date looking at clinically confirmed dementia or AD. This evidence concerns the gene FGF23 and Alzheimer disease.